BibTex RIS Cite

Geçirilmiş miyokarditte antikonjestif tedavi ne zaman kesilmelidir?

Year 2016, Issue: 1, 83 - 85, 01.04.2016

Abstract

Miyokardit miyokard dokusunun enflamasyonu ve miyokard fibrillerinin hasarı ile seyreden bir hastalıktır. Asemptomatik seyirden, kalp yetersizliği ve ani ölüme kadar değişken bulgular gösterir. Tedavinin köşe taşı, antikonjestif ilaçlar ve gerektiğinde mekanik ventilasyonu da kapsayan destekleyici tedavidir. Miyokardit düzeldikten sonra ilaç tedavisinin kesilmesi için en uygun zaman belirsizdir. Burada, izleminin beşinci ayında kalp yetersizliği bulguları düzelen ancak ilaçları kesildikten sonra kalp yetersizliği bulguları tekrarlayan hastayı sunarak antikonjestif tedavinin kesilmesi konusunda temkinli olunması gerektiğini vurgulamak istedik.

When should anticongestive treatment be discontinued following recovery from myocarditis?

Year 2016, Issue: 1, 83 - 85, 01.04.2016

Abstract

Myocarditis is a condition characterized by inflammation and degeneration of myocardial fibres. It shows variable findings changing from asymptomatic clinical course to heart failure and sudden death. The cornerstone of the management is supportive treatment including anticongestive medications and, if required, mechanical ventilation. The appropriate time for discontinuation of those medications following recovery from the disease is unclear. Herein, we present a girl who recovered from myocarditis five months after the diagnosis but had recurrence of heart failure following discontinuation of medications in order to emphasize the importance of being deliberate about cessation of anticongestive drugs.

There are 0 citations in total.

Details

Other ID JA94RA35SR
Journal Section Case Report
Authors

Fikri Demir This is me

Meki Bilici This is me

Alper Akın This is me

Ünal Uluca This is me

Murat Muhtar Yılmazer This is me

Duran Karabel This is me

Publication Date April 1, 2016
Submission Date April 1, 2016
Published in Issue Year 2016 Issue: 1

Cite

APA Demir, F., Bilici, M., Akın, A., Uluca, Ü., et al. (2016). When should anticongestive treatment be discontinued following recovery from myocarditis?. Pamukkale Medical Journal(1), 83-85.
AMA Demir F, Bilici M, Akın A, Uluca Ü, Yılmazer MM, Karabel D. When should anticongestive treatment be discontinued following recovery from myocarditis?. Pam Med J. April 2016;(1):83-85.
Chicago Demir, Fikri, Meki Bilici, Alper Akın, Ünal Uluca, Murat Muhtar Yılmazer, and Duran Karabel. “When Should Anticongestive Treatment Be Discontinued Following Recovery from Myocarditis?”. Pamukkale Medical Journal, no. 1 (April 2016): 83-85.
EndNote Demir F, Bilici M, Akın A, Uluca Ü, Yılmazer MM, Karabel D (April 1, 2016) When should anticongestive treatment be discontinued following recovery from myocarditis?. Pamukkale Medical Journal 1 83–85.
IEEE F. Demir, M. Bilici, A. Akın, Ü. Uluca, M. M. Yılmazer, and D. Karabel, “When should anticongestive treatment be discontinued following recovery from myocarditis?”, Pam Med J, no. 1, pp. 83–85, April 2016.
ISNAD Demir, Fikri et al. “When Should Anticongestive Treatment Be Discontinued Following Recovery from Myocarditis?”. Pamukkale Medical Journal 1 (April 2016), 83-85.
JAMA Demir F, Bilici M, Akın A, Uluca Ü, Yılmazer MM, Karabel D. When should anticongestive treatment be discontinued following recovery from myocarditis?. Pam Med J. 2016;:83–85.
MLA Demir, Fikri et al. “When Should Anticongestive Treatment Be Discontinued Following Recovery from Myocarditis?”. Pamukkale Medical Journal, no. 1, 2016, pp. 83-85.
Vancouver Demir F, Bilici M, Akın A, Uluca Ü, Yılmazer MM, Karabel D. When should anticongestive treatment be discontinued following recovery from myocarditis?. Pam Med J. 2016(1):83-5.

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License